Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | RYTMRhythm Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $189.76M |
| Revenue, yoy | +45.8% |
| Net income | $196.54M |
| Net income, yoy | +24.6% |
| Net margin | -103.6% |
| Free cash flow | $116.63M |
| FCF margin | -61.5% |
| EPS, diluted | $3.11 |
Add another company.